Clinical Trials Logo

Clinical Trial Summary

The objective of this clinical study is to evaluate scar quality following incision with the PEAK PlasmaBlade 4.0 using the Patient and Observer Scar Assessment Scale (POSAS), and to compare these results to equivalently-aged scars formed following incision with a standard scalpel.


Clinical Trial Description

Subjects attended one of two evaluation dates scheduled on January 21, 2011 and February 23, 2011. During this visit, subjects gave informed consent and were instructed on evaluating their breast reduction scars using the Patient Scar Assessment Scale. Following subjects' self-evaluation, each subject was evaluated by three evaluators using the Observer Scar Assessment Scale. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01284491
Study type Interventional
Source Medtronic Surgical Technologies
Contact
Status Terminated
Phase N/A
Start date January 2011
Completion date May 2012

See also
  Status Clinical Trial Phase
Completed NCT05288530 - Satisfaction, Pain and Function Outcomes of Breast Reduction Patients
Completed NCT00986453 - PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction N/A
Completed NCT02769559 - Reduction Mammaplasty and Improved Quality of Life N/A
Terminated NCT02016677 - An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy N/A
Completed NCT00558246 - Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures Phase 4
Recruiting NCT05898087 - Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty Phase 4